Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 447 results for "cadila healthcare"

Pharma shares extend fall; CNX Pharma index down 3%
Business Standard

Focus on innovation: New drugs top Cadila Healthcare's prescri...

Cadila Healthcare is aiming high: it is gunning for revenues of R10,000 crore by FY 2016. India's fourth largest pharmaceutical company, and the manufacturer of India's first new drug Lipaglyn, aims to accelerate growth by expanding product ... Financial Express, 1 day ago
Near-term headwinds for pharma companies Smart Investor, 2 weeks ago
Pharma shares extend fall; CNX Pharma index down 3% Business Standard, 2 weeks ago
India Infoline

Cadila Healthcare's FY15 results on May 15, 2015

Cadila Healthcare has informed that a meeting of the Board of Directors of the Company will be held on May 15, 2015, to approve the audited stand-alone and consolidated financial results for the quarter / year ended on March 31, 2015 and to recommend the ...
 Money Control1 week ago CADILA HEALTHCARE : SEEKS CREDIT LIMIT OF Rs10,000 CRORE  4 Traders3 weeks ago Outcome of board meeting of Cadila Healthcare  Capital Market3 weeks ago Cadila Healthcare plans to raise Up to Rs. 3,500 Cr Via NCD Issue  India Infoline3 weeks ago

Biosimilars should contribute 10% to our revenue in 5 years

In a rare interview, Pankaj Patel, chairman and managing director of India's fourth-largest pharma company, Cadila Healthcare, tells Neha Bothra that the company is looking to expand its biosimilars portfolio through its own R&D efforts and expects ...
 Financial Express1 week ago CADILA HEALTHCARE: BIOSIMILARS SHOULD CONTRIBUTE 10% TO OUR REVENUE IN 5 YEARS  Pharmacy Choice6 days ago

Cadila Healthcare gains on announcing a collaborative program with the National Institute of Alle...

Cadila Healthcare is currently trading at Rs. 1755.80, up by 7.35 points or 0.42 % from its previous closing of Rs. 1748.45 on the BSE. The scrip opened at Rs. 1770.00 and has touched a high and low of Rs. 1770.00 and Rs. 1742.20 respectively. So ...
 Arihant Capital1 week ago Cadila Healthcare gains on inking non-exclusive licensing pact with Gilead Sciences  Arihant Capital1 month ago

Zydus ties up with US-based research centre NIAD to develop vaccine

Cadila Healthcare revealed that its US subsidiary Etna Biotech will collaborate with the US national Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases to develop a vaccine against visceral leishmaniasis, The Economic ...
 FirstWord Pharma1 week ago Zydus ties up with US-based R&D to develop vaccine  Hindu Business Line1 week ago Zydus ties up with US-based RD centre to develop vaccine  Moneycontrol.com1 week ago

Sharekhan's top 12 picks which may give up to 50% return in next 6-12 months

NEW DELHI: The Indian equity market has underperformed other emerging markets in the last few months due to rising concerns over subdued growth in the earnings of domestic corporates, possibility of a delayed revival in economic activity, unseasonal ...
 Economic Times10 hours ago 10 stocks in focus; Sensex ignores Moody's  Economic Times3 weeks ago Top 12 stocks which can deliver up to 50% return  Economic Times1 month ago

Ahmedabad-based pharma firms bank on wellness

AHMEDABAD: Pharma companies in Gujarat are increasingly focusing on . Several companies are either expanding their existing line of personal care products or setting up new divisions to cater to the growing wellness market in the country. For ...
 Times of India1 day ago Gujarat's pharma firms bank on wellness  Times of India1 day ago

If IIM bill promotes centralization, it's bad news: Ashish Nanda

If the proposed bill on Indian Institutes of Management (IIM) is used to bring about centralization of key processes, it would be bad news for these institutions and their autonomy, believes Ashish Nanda , director of IIM Ahmedabad (IIMA) India's ...
 Livemint.com1 day ago

Antithrombotic Drugs: World Industry and Market Prospects 2015-2025

/PRNewswire/ -- A new report by visiongain forecasts the overall world market for antithrombotic drugs will reach $22.4bn in 2019. That revenue forecast and others appear in , published in March 2015 . The purpose of that investigation is to ...
 Tamar Securities4 days ago

Tata Motors, Maruti, Sun Pharma to get astro support: Gupta

Today's planetary position: Moon will be transiting in Virgo. Jupiter in Cancer. Lord Rahu in Virgo, Lord Saturn in Scorpio. Mars and Sun in Aries, Venus and Mercury in Taurus, Ketu in Pisces. Pluto in Sagittarius. Neptune in Aquarius and Uranus in ...
 Moneycontrol.com5 days ago Stock market prediction for March 9-13: Satish Gupta  Moneycontrol.com1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - cadila healthcare
Get updated on latest news & your favorite topics right in your inbox!
More     Less